Which pharmaceutical companies sell the most pills?
Health care experts are divided on whether prescription drug companies sell enough generic versions of the same drugs for the price of branded versions.
But a survey by Bloomberg shows the number of generic versions sold in the United States rose by almost 6 percent from 2016 to 2018.
The most popular generic drugs were OxyContin and Zoloft, both sold in Canada.
That’s down from more than 5 percent in 2015.
There were 2.4 million generic versions available in 2018, according to the survey.
Generic versions of some prescription drugs, including Viagra and Cialis, rose more than 15 percent from last year.
But many patients aren’t interested in generic versions and prefer brand versions of those drugs.
Generic prescriptions in 2018 were nearly double the amount of branded prescriptions.
In 2018, 1.6 million generic prescriptions were dispensed, according a Bloomberg survey.
The pharmaceutical industry has said it is committed to increasing supply of generic drugs, but the lack of generic competition may limit how much it can offer.
The U.S. Food and Drug Administration has banned sales of generic copies of some medications, including Cialus, since 2017.
Generic medications can cost up to 70 percent more than brand versions.
The agency has also approved generic versions for the treatment of certain cancers.
But the Trump administration has said generic versions are no better or worse than branded versions, and has proposed the creation of an agency that would oversee generic sales.
The FDA is currently considering a new rule that would require pharmaceutical companies to obtain approval from the agency before selling generic versions.
A spokeswoman for the agency, Catherine F. Woodside, said the agency does not have any plans to create an agency to oversee generic prescriptions.
FDA officials have not responded to questions about the survey results.
“It’s an interesting study to look at how much generic versions cost and how much they cost, but it’s not a gold standard,” said Robert Hirsch, a vice president at the Pharmaceutical Research and Manufacturers of America, a trade group.
“I would caution against over-simplifying.”
The survey showed that generics were cheaper than brand drugs by about 2 percent.
For example, OxyContin, which is approved in Canada and other countries, cost $8.25 per pill in 2018.
It’s about the same as the cost of a brand version of the drug, according the Bloomberg survey, which asked patients to choose their preferred brand and a generic version of it.
The survey also showed that brand versions were less expensive than generic versions, which cost $3.75 per pill.
Generic brand versions cost about $11 more than generic generic versions at a brand-name pharmacy.
The study found that brand-brand versions were about twice as expensive as generic versions by a factor of three, with brands of the most popular brands costing about $5,000 more per pill than generic brands.
The drug companies are also selling generic version products in countries that have lower prices than the U. S. But some experts say generic versions may be less expensive, especially in the U., where the U’s government has pushed for generic versions to be allowed in the market.
The Affordable Care Act prohibits insurers from charging people higher prices than brand-branded drugs.
That would mean more generic versions will be sold.
A study last year by Avalere Health found that about 30 percent of people would use brand-specific versions of generic oxycodone, but less than 5 to 10 percent would use generic versions like Cialid.